CARDIFF ONCOLOGY, INC. Other Operating Income (Expense), Net
CARDIFF ONCOLOGY, INC. (CRDF) reported Other Operating Income (Expense), Net of -$28.24 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2021-02-25
- CARDIFF ONCOLOGY, INC. other operating income (expense), net for fiscal 2020 was -$28.24K, a 1527.91% decline from fiscal 2019.
- CARDIFF ONCOLOGY, INC. other operating income (expense), net for fiscal 2019 was $1.98K.
- CARDIFF ONCOLOGY, INC. other operating income (expense), net for fiscal 2018 was -$236.83K.
- CARDIFF ONCOLOGY, INC. other operating income (expense), net for fiscal 2017 was -$170.14K.
| Period end | Other Operating Income (Expense), Net 12 month |
|---|---|
| 2020-12-31 | -$28.24K 10-K · filed 2021-02-25 |
| 2019-12-31 | $1.98K 10-K · filed 2021-02-25 |
| 2018-12-31 | -$236.83K 10-K · filed 2020-02-27 |
| 2017-12-31 | -$170.14K 10-K · filed 2019-03-06 |
| 2016-12-31 | -$144.73K 10-K · filed 2018-02-26 |
| 2015-12-31 | -$2.80K 10-K · filed 2017-03-15 |
| 2014-12-31 | $24.84K 10-K · filed 2017-03-15 |
| 2013-12-31 | -$22.94K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |